Erlocip 150 Erlocip 150 contains Erlotinib 150 mg, a targeted anti-cancer medicine used to treat certain cancers that have specific EGFR mutations. It works by blocking the signals that cancer cells rely on to grow and multiply, helping to slow the progression of the disease. Erlocip 150 is prescribed as part of a personalized treatment plan under the supervision of an oncologist.